Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Prostatic Neoplasms 12Leukemia 12Lymphoma 7Burkitt Lymphoma 7Leukemia, Biphenotypic, Acute 6Lymphoma, Large B-Cell, Diffuse 5Recurrence 4Lymphoma, Non-Hodgkin 4Pituitary Neoplasms 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell 3Leukemia, Myeloid, Acute 3Hodgkin Disease 3Rhabdoid Tumor 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Obesity 2Neoplasms 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Hematologic Neoplasms 2Radiodermatitis 1Pyloric Stenosis, Hypertrophic 1Plasmablastic Lymphoma 1Pituitary Diseases 1Pinealoma 1

Interventions

Gemcitabine 406Oxaliplatin 131Fluorouracil 125130-nm albumin-bound paclitaxel 108Capecitabine 100Albumin-Bound Paclitaxel 90Leucovorin 88Irinotecan 87Radiotherapy 76Radiosurgery 64Taxes 63Cisplatin 56Erlotinib Hydrochloride 44Drug Therapy 42folfirinox 40Magnetic Resonance Spectroscopy 39pembrolizumab 35Blood Specimen Collection 33S 1 (combination) 31Pancreaticoduodenectomy 31Docetaxel 31Nivolumab 30Bevacizumab 30Biopsy 26Surgical Procedures, Operative 25Cyclophosphamide 25irinotecan sucrosofate 24Specimen Handling 24Radiation 22Standard of Care 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Neoplasms × Hydrocortisone × Clear all
NCT02775227 2020-08-24

HYPAR

Helsinki University Central Hospital

Phase 4 Active not recruiting
126 enrolled
Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡